Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-050938
Filing Date
2021-08-11
Accepted
2021-08-11 17:15:42
Documents
1
Period of Report
2021-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4069
  Complete submission text file 0001209191-21-050938.txt   5562
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Issuer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O MAXCYTE, INC. 22 FIRSTFIELD ROAD, SUITE 110 GAITHERSBURG MD 20878
Business Address
Holtz Ron (Reporting) CIK: 0001874490 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40674 | Film No.: 211164574